Literature DB >> 23680737

Carotid artery intima-media thickness and the renin-angiotensin system.

Christopher T Johnson1, Luke P Brewster.   

Abstract

Carotid artery intima-media thickness (IMT) is a biomarker for cardiovascular disease that also predicts the risk of cardiovascular mortality. Angiotensin-converting enzyme (ACE) inhibition is a unique therapeutic modality because it both treats hypertension and improves arterial health and cardiovascular disease outcomes. Controversy exists regarding the role of ACE inhibitors and angiotensin receptor blockers (ARBs) in IMT regression. Our article provides an update on how ACE inhibitors and ARBs could play a role in decreasing IMT.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23680737      PMCID： PMC4040131          DOI： 10.3810/hp.2013.04.1026

Source DB:  PubMed          Journal:  Hosp Pract (1995)        ISSN： 2154-8331


  80 in total

Review 1.  Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis.

Authors:  Matthias W Lorenz; Hugh S Markus; Michiel L Bots; Maria Rosvall; Matthias Sitzer
Journal:  Circulation       Date:  2007-01-22       Impact factor: 29.690

Review 2.  Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine.

Authors:  James H Stein; Claudia E Korcarz; R Todd Hurst; Eva Lonn; Christopher B Kendall; Emile R Mohler; Samer S Najjar; Christopher M Rembold; Wendy S Post
Journal:  J Am Soc Echocardiogr       Date:  2008-02       Impact factor: 5.251

3.  Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension.

Authors:  Hiroyoshi Ono; Shinya Minatoguchi; Kazuhiro Watanabe; Yoshihisa Yamada; Takahisa Mizukusa; Hironobu Kawasaki; Hidemi Takahashi; Takashi Uno; Tatsuo Tsukamoto; Kunihiko Hiei; Hisayoshi Fujiwara
Journal:  Hypertens Res       Date:  2008-02       Impact factor: 3.872

4.  Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population.

Authors:  Gian Paolo Fadini; Anna Coracina; Ilenia Baesso; Carlo Agostini; Antonio Tiengo; Angelo Avogaro; Saula Vigili de Kreutzenberg
Journal:  Stroke       Date:  2006-07-27       Impact factor: 7.914

Review 5.  Pathological involvement of chymase-dependent angiotensin II formation in the development of cardiovascular disease.

Authors:  H Urata
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2000-06       Impact factor: 1.636

6.  Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension.

Authors:  Ben Ariff; Andrew Zambanini; Sarita Vamadeva; Dean Barratt; Yun Xu; Peter Sever; Alice Stanton; Alun Hughes; Simon Thom
Journal:  Stroke       Date:  2006-08-03       Impact factor: 7.914

7.  Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile.

Authors:  Asia Rehman; Shaiful Bahari Ismail; Lin Naing; Tariq Mahmood Roshan; Abdul Rashid Abdul Rahman
Journal:  Am J Hypertens       Date:  2007-02       Impact factor: 2.689

Review 8.  Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension.

Authors:  Guido Grassi; Fosca Quarti-Trevano; Giuseppe Mancia
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2008-06       Impact factor: 1.636

9.  A one-year study of the antiatherosclerotic effect of the angiotensin-II receptor blocker losartan in hypertensive patients. A comparison with angiotension-converting enzyme inhibitors.

Authors:  Makoto Sonoda; Teruhiko Aoyagi; Katsu Takenaka; Kansei Uno; Ryozo Nagai
Journal:  Int Heart J       Date:  2008-01       Impact factor: 1.862

10.  Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.

Authors:  D Mörtsell; K Malmqvist; C Held; T Kahan
Journal:  J Intern Med       Date:  2007-05       Impact factor: 8.989
View more
  2 in total

1.  Pathophysiology and Medical Treatment of Carotid Artery Stenosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2015-06-23

2.  Urate-lowering therapy alleviates atherosclerosis inflammatory response factors and neointimal lesions in a mouse model of induced carotid atherosclerosis.

Authors:  Jie Lu; Mingshu Sun; Xinjiang Wu; Xuan Yuan; Zhen Liu; Xiaojie Qu; Xiaopeng Ji; Tony R Merriman; Changgui Li
Journal:  FEBS J       Date:  2019-02-09       Impact factor: 5.542
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.